deafness

Fierce Pharma

Regeneron ushers in new era with inaugural gene therapy approval

The FDA today approved the company’s Otarmeni, the first gene therapy for a rare genetic form of hearing loss that affects about 50 newborns per year.

Darren Incorvaia Apr 23, 2026 3:22pm

Regeneron shares updated data on hearing loss gene therapy

Oct 12, 2025 10:18am

hearing deaf pediatrics audiologist doctor children

Regeneron's 'protein factory' gene therapy restores hearing

May 8, 2024 6:00am

Sensorion spins hearing loss flop into exploratory win

Mar 17, 2022 10:32am

New discoveries in cancer and hearing loss—News of Note

Jul 8, 2019 11:14am

Neuron discovery could yield new treatments for hearing loss

Sep 13, 2018 4:25pm